Medtronic plc (MDT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-24. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 15B 30B 45B Q1 '22: 31.6B Q2 '22: 31.8B Q3 '22: 31.8B Q4 '22: 31.7B Q1 '23: 31.1B Q2 '23: 30.8B Q3 '23: 30.8B Q4 '23: 31.2B Q1 '24: 31.6B Q2 '24: 32B Q3 '24: 32.3B Q4 '24: 32.4B Q1 '25: 32.6B Q2 '25: 33B Q3 '25: 33.2B Q4 '25: 33.5B Q1 '26: 34.2B Q2 '26: 34.8B Q3 '26: 35.5B Q4 '26: 36.4B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Gross Profit TTM

0 8B 16B 24B Q1 '16: 15.6B Q2 '16: 17.3B Q3 '16: 18.9B Q4 '16: 19.7B Q1 '17: 19.8B Q2 '17: 19.9B Q3 '17: 20.1B Q4 '17: 20.4B Q1 '18: 20.6B Q2 '18: 20.5B Q3 '18: 20.6B Q4 '18: 20.9B Q1 '19: 21B Q2 '19: 21.4B Q3 '19: 21.5B Q4 '19: 21.4B Q1 '20: 21.3B Q2 '20: 21.4B Q3 '20: 21.4B Q4 '20: 19.5B Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Operating Income TTM

0 2.5B 5B 7.5B Q1 '22: 4.7B Q2 '22: 5.3B Q3 '22: 5.7B Q4 '22: 5.8B Q1 '23: 6B Q2 '23: 5.9B Q3 '23: 5.6B Q4 '23: 5.5B Q1 '24: 5.6B Q2 '24: 5.6B Q3 '24: 5.7B Q4 '24: 5.1B Q1 '25: 5.2B Q2 '25: 5.4B Q3 '25: 5.6B Q4 '25: 6B Q1 '26: 6.1B Q2 '26: 6.2B Q3 '26: 6B Q4 '26: 6.5B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Net Income TTM

0 2B 4B 6B Q1 '22: 3.9B Q2 '22: 4.7B Q3 '22: 4.9B Q4 '22: 5B Q1 '23: 5.2B Q2 '23: 4.3B Q3 '23: 4.1B Q4 '23: 3.8B Q1 '24: 3.6B Q2 '24: 4.1B Q3 '24: 4.2B Q4 '24: 3.7B Q1 '25: 3.9B Q2 '25: 4.3B Q3 '25: 4.3B Q4 '25: 4.7B Q1 '26: 4.7B Q2 '26: 4.8B Q3 '26: 4.6B Q4 '26: 4.8B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Cost of Revenue TTM

0 5B 10B 15B Q1 '22: 10.6B Q2 '22: 10.4B Q3 '22: 10.2B Q4 '22: 10.1B Q1 '23: 10.1B Q2 '23: 10.1B Q3 '23: 10.3B Q4 '23: 10.7B Q1 '24: 10.8B Q2 '24: 11.1B Q3 '24: 11.2B Q4 '24: 11.2B Q1 '25: 11.3B Q2 '25: 11.5B Q3 '25: 11.5B Q4 '25: 11.6B Q1 '26: 11.9B Q2 '26: 12B Q3 '26: 12.5B Q4 '26: 12.7B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Operating Cash Flow TTM

0 2.5B 5B 7.5B Q1 '22: 7.3B Q2 '22: 7.2B Q3 '22: 7B Q4 '22: 7.3B Q1 '23: 7.1B Q2 '23: 6.3B Q3 '23: 5.6B Q4 '23: 6B Q1 '24: 5.8B Q2 '24: 5.6B Q3 '24: 6.5B Q4 '24: 6.8B Q1 '25: 6.9B Q2 '25: 7.2B Q3 '25: 7.3B Q4 '25: 7B Q1 '26: 7.1B Q2 '26: 7.1B Q3 '26: 7.3B Q4 '26: 7.3B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Free Cash Flow TTM

0 2.5B 5B 7.5B Q1 '22: 5.9B Q2 '22: 5.8B Q3 '22: 5.7B Q4 '22: 6B Q1 '23: 5.7B Q2 '23: 4.8B Q3 '23: 4.2B Q4 '23: 4.6B Q1 '24: 4.4B Q2 '24: 4B Q3 '24: 4.9B Q4 '24: 5.2B Q1 '25: 5.1B Q2 '25: 5.5B Q3 '25: 5.5B Q4 '25: 5.2B Q1 '26: 5.3B Q2 '26: 5.2B Q3 '26: 5.4B Q4 '26: 5.4B Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q2 '20: 1.4B Q3 '20: 1.4B Q1 '21: 1.4B Q2 '21: 1.4B Q3 '21: 1.4B Q1 '22: 1.4B Q2 '22: 1.4B Q3 '22: 1.4B Q1 '23: 1.3B Q2 '23: 1.3B Q3 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q1 '25: 1.3B Q2 '25: 1.3B Q3 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.3B Q3 '26: 1.3B Q3 '20 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q1 '22: 2.86 Q2 '22: 3.47 Q3 '22: 3.63 Q4 '22: 3.73 Q1 '23: 3.87 Q2 '23: 3.22 Q3 '23: 3.04 Q4 '23: 2.82 Q1 '24: 2.71 Q2 '24: 3.07 Q3 '24: 3.14 Q4 '24: 2.75 Q1 '25: 2.96 Q2 '25: 3.27 Q3 '25: 3.29 Q4 '25: 3.62 Q1 '26: 3.63 Q2 '26: 3.71 Q3 '26: 3.59 Q4 '26: 3.74 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q1 '26 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.